-
‘Scum of the Earth': Drug Victims Face Purdue Pharma Owners
Addiction and overdose survivors and those who have lost loved ones have unleashed their emotions on members of the family they blame for fueling the opioid epidemic
-
New Purdue Pharma Deal Has Victims' Families Deflated, Angry But Hopeful
A new, tentative settlement reached Thursday would force the Sacklers to pay out billions, and allow victims to directly share their heartache with Sackler family members by videoconference.
-
Suits Against OxyContin Owners on Hold; Negotiations Ordered
A judge has kept lawsuits against OxyContin maker Purdue Pharma and members of the Sackler family who own it on hold until Feb. 1 but ordered the parties to negotiate a new settlement.
-
Judge Rejects Purdue Pharma's Sweeping Opioid Settlement
A federal judge has rejected OxyContin maker Purdue Pharma’s sweeping deal to settle thousands of lawsuits over the toll of opioids.
-
Metropolitan Museum of Art Cuts Sackler Name Amid Opioid Ire
The Metropolitan Museum of Art is dropping the Sackler name from seven exhibition spaces amid growing outrage over the role the family may have played in the opioid crisis.
-
Companies: $26B Settlement of Opioid Lawsuits to Move Ahead
Four companies say they’ll move ahead with a $26 billion settlement of lawsuits over the opioid crisis.
-
‘Sweetheart Deal' With OxyContin Maker Leaves Families Angry, Conflicted
A landmark settlement in the nation’s opioid epidemic is forcing the owners of OxyContin maker Purdue Pharma to give up the company and pay out $4.5 billion
-
Judge Conditionally Approves Purdue Pharma Opioid Settlement
A federal bankruptcy judge has approved with conditions a historic opioid settlement between Purdue Pharma and thousands of local and state governments
-
Purdue: Settlement Better for States Than Continuing Suits
A Purdue Pharma lawyer says states would get more money from settling with the company than if they were allowed to continue their lawsuits against the OxyContin maker and members of the Sackler family who own it
-
OxyContin Maker's Lawyer Warns of Long, Expensive Litigation
A lawyer for Purdue Pharma says the company’s settlement plan is the only way to avoid long and expensive litigation.
-
Ex-Chair of Purdue Denies Responsibility for Opioid Crisis
Former Purdue Pharma president and chair Richard Sackler says he, his family and the company do not have any responsibility for the opioid crisis in the United States
-
Heir: Sacklers Won't Settle Unless Freed From Opioid Suits
A member of the family that owns Purdue Pharma has told a court that the family will not contribute billions to abate the U.S. opioid crisis unless it is granted protection from current and future lawsuits
-
Healey Hails $4.3B Settlement With Purdue Pharma
Massachusetts Attorney General Maura Healey announced Thursday that, with the resolution of her lawsuit against members of the Sackler family and their company, Purdue Pharma, she will make public tens of millions of documents related to their role in the opioid crisis, and require a payment of more than $4.3 billion over the next nine years. Purdue Pharma will also…
-
More States Agree to Settlement Plan for Opioid-Maker Purdue Pharma
More than a dozen states have dropped their objections to OxyContin maker Purdue Pharma’s reorganization plan, edging the company closer to resolving its bankruptcy case.
-
Advocates, Some AGs Wary of Purdue Pharma Bankruptcy Plan
OxyContin maker Purdue Pharma has a $10 billion plan to transform into a new company dedicated to fighting the opioid crisis, but its not a done deal yet
-
Family Behind OxyContin Attests to Its Role in Opioid Crisis
Two members of the Sackler family that owns OxyContin maker Purdue Pharma have acknowledged the drug had a role in the opioid epidemic
-
Purdue Pharma Pleads Guilty for Role in Opioid Crisis
Purdue Pharma, the manufacturer of the painkiller Oxycontin, pleaded guilty to charges for its role in the opioid crisis.
-
OxyContin Maker Purdue Pharma Pleads Guilty in Criminal Case
Purdue Pharma says its guilty plea over its role in the opioid crisis is “an essential step to preserve billions of dollars” for the settlement it is pursuing in bankruptcy court
-
Bankruptcy Judge OKs Federal Settlement With Purdue Pharma
A bankruptcy judge has given his approval to OxyContin maker Purdue Pharma’s $8 billion settlement with the U.S. Department of Justice.
-
Purdue Pharma Agrees to Plead Guilty Over Aggressive OxyContin Marketing
The Department of Justice announced Wednesday that Purdue Pharma agreed to plead guilty to criminal charges for their marketing of OxyContin.